IP Library Granted Patent US 9,814,670
Granted Patent B2
US 9,814,670 · App. 14/959,893 · Granted Nov 14, 2017

Cosmetic compositions

Inventors: David Gan (Southlake, TX); Milagros Sanchez (Addison, TX); Wanli Zhao (Addison, TX)
Assignee: Mary Kay Inc.
A61K8/97A61K8/042A61K8/062A61K8/31A61K8/34A61K8/342A61K8/345A61K8/37A61K8/375A61K8/41A61K8/42A61K8/44A61K8/4973A61K8/55A61K8/585A61K8/64A61K8/8152A61K8/86A61K8/891A61K8/894A61K8/922A61K8/99A61K36/185A61K36/45A61K38/06A61K38/07A61Q19/00A61Q19/02A61Q19/08A61K2800/594A61K2800/5922
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,814,670
App. No.
14/959,893
Granted
Nov 14, 2017
Kind
B2
Abstract

Disclosed are compositions and methods for their use that include a combination of Rhododendron ferrugineum (alpine rose) extract, Oenothera biennis (evening rose) extract, trifluoroacetyl tripeptide-2, and a cosmetic acceptable vehicle.

Claims (107)

1. A topical skin care composition comprising:

(a) an effective amount of Rhododendron ferrugineum (alpine rose) leaf extract for reducing (1) cyclo-oxygenase 1 activity, (2) cyclo-oxygenase 2 activity, and (3) lipoxygenase activity in skin, wherein the Rhododendron ferrugineum (alpine rose) leaf extract comprises flavonoids and is a water and glycerin extract;

(b) an effective amount of Oenothera biennis (evening primrose) seed extract for increasing type I collagen production in skin, wherein the Oenothera biennis (evening primrose) seed extract comprises Oenothera biennis seed oil;

(c) an effective amount of trifluoroacetyl tripeptide-2 for increasing type I collagen production in skin; and

(d) a cosmetically acceptable vehicle.

2. The topical skin care composition of claim 1 , comprising 0.01 to 2 wt. % of Rhododendron ferrugineum (alpine rose) leaf extract, 0.1 to 2 wt. % of Oenothera biennis (evening primrose) seed extract, and 0.0001 to 2 wt. % of trifluoroacetyl tripeptide-2.

3. The topical skin composition of claim 1 , wherein the cosmetically acceptable vehicle comprises:

water;

glycerin;

acrylates/C10-30 alkyl acrylate crosspolymer;

disodium ethylenediaminetetraacetic acid;

triethanolamine;

polydimethylsiloxane; and

polymethyl methylacrylate.

4. The topical skin composition of claim 3 , wherein the cosmetically acceptable vehicle comprises:

50 to 75 wt. % water;

1 to 15 wt. % glycerin;

0.1 to 0.5 wt. % acrylates/C10-30 alkyl acrylate crosspolymer;

0.05 to 0.15 wt. % disodium ethylenediaminetetraacetic acid;

0.1 to 1.5 wt. % triethanolamine;

2 to 5 wt. % polydimethylsiloxane; and

0.5 to 1 wt. % polymethyl methylacrylate.

5. The topical skin composition of claim 3 , wherein the composition is formulated as an oil-in-water emulsion and the cosmetically acceptable vehicle comprises 55 to 70 wt. % water and further comprises:

glyceryl stearate;

pentylene glycol;

ethylhexyl isononanoate;

cetyl alcohol;

butyrosperum parkii (shea) butter;

zea mays (corn) germ oil;

cetyl phosphate;

cetearyl alcohol; and

ceteareth-33.

6. The topical skin composition of claim 5 , wherein the composition further comprises:

3 to 7 wt. % glyceryl stearate;

3 to 7 wt. % pentylene glycol;

2 to 5 wt. % ethylhexyl isononanoate;

2 to 5 wt. % cetyl alcohol;

1 to 3 wt. % butyrosperum parkii (shea) butter;

1 to 3 wt. % zea mays (corn) germ oil;

1 to 3 wt. % cetyl phosphate;

1 to 3 wt. % cetearyl alcohol; and

0.5 to 1 wt. % ceteareth-33.

7. The topical skin composition of claim 1 , wherein the cosmetically acceptable vehicle comprises:

water;

glyceryl stearate;

cetyl phosphate;

cetearyl alcohol;

ceteareth-33; and

carbomer.

8. The topical skin composition of claim 7 , wherein the cosmetically acceptable vehicle comprises:

40 to 75 wt. % water;

4 to 10 wt. % glyceryl stearate;

0.5 to 5 wt. % cetyl phosphate;

0.5 to 5 wt. % cetearyl alcohol;

0.1 to 3 wt. % ceteareth-33; and

0.1 to 3 wt. % carbomer.

9. The topical skin composition of claim 7 , wherein the composition is formulated as an oil-in-water emulsion and the cosmetically acceptable vehicle comprises 45 to 60 wt. % water and further comprises:

butyrospermum parkii (shea) butter;

zea mays (corn) germ oil;

pentylene glycol;

dimethicone;

glycerin;

triethanolamine;

polymethyl methacrylate; and

phenoxyethanol.

10. The topical skin composition of claim 9 , wherein the composition comprises:

2 to 10 wt. % butyrospermum parkii (shea) butter;

2 to 10 wt. % zea mays (corn) Germ oil;

1 to 7 wt. % pentylene glycol;

0.5 to 5 wt. % dimethicone;

0.5 to 5 wt. % glycerin;

0.1 to 3 wt. % triethanolamine;

0.1 to 3 wt. % polymethyl methacrylate; and

0.1 to 3 wt. % phenoxyethanol.

11. The topical skin composition of claim 3 , wherein the composition is formulated as a serum and the cosmetically acceptable vehicle comprises 60 to 70 wt. % water and further comprises:

butylene glycol;

cyclopentasiloxane;

hydrogenated polydecene;

dimethicone/vinyl dimethicone cross polymer;

capryl glycol;

1,2-hexanediol;

hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer;

polysorbate 20;

squalane; and

panthenol.

12. The topical skin composition of claim 11 , comprising:

3 to 7 wt. % butylene glycol;

3 to 7 wt. % cyclopentasiloxane;

2 to 5 wt. % hydrogenated polydecene;

1 to 3 wt. % dimethicone/vinyl dimethicone cross polymer;

0.1 to 1 wt. % capryl glycol;

0.1 to 1 wt. % 1,2-hexanediol;

0.1 to 1 wt. % hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer;

0.1 to 1 wt. % polysorbate 20;

0.1 to 1 wt. % squalane; and

0.1 to 1 wt. % panthenol.

13. The topical skin care composition of claim 1 , wherein the Rhododendron ferrugineum (alpine rose) leaf extract is in an amount that reduces TNF-alpha production and melanocyte pigmentation in skin.

14. The topical skin care composition of claim 1 , wherein the composition is a cream, lotion, or serum.

15. The topical skin care composition of claim 1 , wherein the composition is an emulsion or serum.

16. A method of applying the composition of claim 1 to skin comprising topically applying the composition of claim 1 to skin.

17. The method of claim 16 , wherein the composition is applied to a fine line or wrinkle.

18. The method of claim 16 , wherein the composition is applied to the periorbital area of a person's face.

19. The method of claim 18 , wherein the composition is applied to under eye bags or under eye dark circles.

20. The method of claim 16 , wherein the composition reduces cyclo-oxygenase 1 activity, cyclo-oxygenase 2 activity, and lipoxygenase activity in the skin.

21. The method of claim 16 , wherein the composition increases type I collagen production in the skin.

22. The method of claim 16 , wherein the composition reduces TNF-alpha production or melanocyte pigmentation in the skin.

23. A method of lighting skin, the method comprising topically applying the composition of claim 1 to skin, wherein said composition lightens skin by reducing melanocyte pigmentation in skin.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2022
From: MARY KAY INC.
To: ALLUSTRA TECHNOLOGIES LLC
Reel/Frame 061625/0359 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2016
From: GAN, DAVID; SANCHEZ, MILAGROS; ZHAO, WANLI
To: MARY KAY INC.
Reel/Frame 040463/0178 →
Continuity (2)
Provisional Application 62087658 · Dec 4, 2014
Related Publication 20160158143A1 · Jun 9, 2016